Christopher Malozzi is a Cardiology physician affiliated with University of South Alabama Medical Center. OpenAlex indexes 114 publications with 220 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20255 payments
- Boston Scientific CorporationProgram year20254 payments
- Baxter HealthcareProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.7%Beta blocker20.8%Metoprolol Succinate47%Carvedilol36%Metoprolol Tartrate17%Part D≥58 patientsStatin16.1%Atorvastatin Calcium57%Rosuvastatin Calcium34%Pravastatin Sodium4%Simvastatin4%Part D<11 patients+ 11 more classes in this area
Blood & clotting
21.9%Factor Xa inhibitor12.9%Eliquis94%Xarelto6%Part D<11 patientsP2Y12 inhibitor4.7%Clopidogrel100%Part D≥27 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.4%Potassium supplement1.9%Potassium Chloride100%Part D<11 patientsProton pump inhibitor0.8%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spontaneously-Vanishing Pericardial Cyst!
Zenodo (CERN European Organization for Nuclear Research)
2026 - Atrial Versus Ventricular Ectopy: The Ashman Phenomenon!
Zenodo (CERN European Organization for Nuclear Research)
2026 - 26-CCC-14754-ACC PERICARDIAL EFFUSION AS THE INITIAL MANIFESTATION OF HODGKIN LYMPHOMA
Journal of the American College of Cardiology
2026 - Brugada Phenocopy Amidst A Metabolic Catastrophe!
Zenodo (CERN European Organization for Nuclear Research)
2026 - Subclavian Stenosis: Conundrum Of LIMA Utility During CABG!
Zenodo (CERN European Organization for Nuclear Research)
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Jacek Polski, MD
University of South Alabama Medical Center
Jing Zhou
University of South Alabama Medical Center
Hamayun Imran, MBBS
University of South Alabama Medical Center
Bassam Omar, MD
University of South Alabama Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”